Self-Treated Hypoglycemia in Type 2 Diabetes Mellitus: Results from the Second Wave of an International Cross-Sectional Survey

Diabetes Therapy

Volumn 7, Issue 2, 2016, Pages 279-293

  Brod, Meryl ^a   Galstyan, Gagik ^b   Unnikrishnan, Ambika Gopalakrishnan ^c   Harman Boehm, Ilana ^d   Prusty, Vinay ^e   Lavalle, Fernando ^f   McGill, Margaret ^g   Murphy, Angela ^h   Puchulu, Felix ⁱ  

^a Brod Group   (United States)

^b ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^c Chellaram Diabetes Institute   (India)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^e NOVO NORDISK A S   (Denmark)

^f UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^g UNIVERSITY OF SYDNEY   (Australia)

^h Sunward Park Medical Centre   (South Africa)

ⁱ UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

GAPP2; Minor hypoglycemia; Nocturnal hypoglycemia; Self treated hypoglycemia; Type 2 diabetes mellitus

Indexed keywords

INSULIN DERIVATIVE;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NOCTURNAL HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF CARE;

EID: 84975865155     PISSN: 18696953     EISSN: 18696961     Source Type: Journal    
DOI: 10.1007/s13300-016-0164-0     Document Type: Article

References (18)

1. Hayes RP, Fitzgerald JT, Jacober SJ. Primary care physician beliefs about insulin initiation in patients with type 2 diabetes. Int J Clinl Pract. 2008;62:860–8.
2. Karter AJ, Subramanian U, Saha C, Crosson JC, Parker MM, Swain BE, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care. 2010;33:733–5.
3. Brod M, Rana A, Barnett AH. Impact of self-treated hypoglycaemia in type 2 diabetes: a multinational survey in patients and physicians. Curr Med Res Opin. 2012;28:1947–58.
4. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care. 2013;36:1384–95.
5. Brod M, Christensen T, Bushnell DM. Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey. J Med Econ. 2012;15:77–86.
6. Brod M, Wolden M, Christensen T, Bushnell DM. A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function. Diabetes Obes Metab. 2013;15:546–57.
7. Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011;14:665–71.
8. Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res. 2013;13:123–30.
9. Jensen MM, Pedersen-Bjergaard U. Self-reported frequency and impact of non-severe hypoglycemic events in insulin-treated diabetic patients in Denmark. Diabetes Management. 2014;5:67–78.
10. Parekh WA, Ashley D, Chubb B, Gillies H, Evans M. Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel local impact of hypoglycaemia tool. Diabet Med. 2015;32:1156–66.
11. Foos V, Varol N, Curtis BH, Boye KS, Grant D, Palmer JL, et al. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ. 2015;18:420–32.
12. Brod M, Peyrot M, Rana A, Barnett AH. GAPP2™: global survey of type 2 diabetes insulin analogue users shows extensive impact of self-treated hypoglycaemia and dosing irregularities on diabetes management in primary care. Prim Care Diabetes. 2013;7:78.
13. Munro N, Barnett AH. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycaemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. Int J Clin Pract. 2014;68:692–9.
14. Fulcher G, Singer J, Castaneda R, Fraige Filho F, Maffei L, Snyman J, et al. The psychosocial and financial impact of non-severe hypoglycemic events on people with diabetes: two international surveys. J Med Econ. 2014;17:751–61.
15. Levy AR, Christensen TL, Johnson JA. Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom. Health Qual Life Outcomes. 2008;6:73.
16. Leiter LA, Yale J, Chiasson J, Harris SB, Kleinstiver P, Sauriol L. Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management. Can J Diabetes. 2005;29:186–92.
17. Sakane N, Kotani K, Tsuzaki K, Nishi M, Takahashi K, Murata T, et al. Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus. J Diabetes Investig. 2015;6:567–70.
18. Brod M, Pohlman B, Wolden M, Christensen T. Non-severe nocturnal hypoglycaemic events: experience and impacts on patient functioning and well-being. Qual Life Res. 2013;22:997–1004.